Ramanan AV - Search Results

1

Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials.

Ruperto N, Brunner HI, Quartier P, Constantin T, Wulffraat NM, Horneff G, Kasapcopur O, Schneider R, Anton J, Barash J, Berner R, Corona F, Cuttica R, Fouillet-Desjonqueres M, Fischbach M, Foster HE, Foell D, Radominski SC, Ramanan AV, Trauzeddel R, Unsal E, Levy J, Vritzali E, Martini A, Lovell DJ; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG). Ruperto N, et al. Among authors: ramanan av. Ann Rheum Dis. 2018 Dec;77(12):1710-1719. doi: 10.1136/annrheumdis-2018-213150. Epub 2018 Sep 29. Ann Rheum Dis. 2018. PMID: 30269054 Free PMC article. Clinical Trial.

2

Atrophoderma and juvenile idiopathic arthritis.

Ramanan AV, Baildam EM, Judge MR. Ramanan AV, et al. Ann Rheum Dis. 2001 Sep;60(9):900-1. Ann Rheum Dis. 2001. PMID: 11534508 Free PMC article. No abstract available.

3

Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis.

Ramanan AV, Schneider R. Ramanan AV, et al. J Rheumatol. 2003 Feb;30(2):401-3. J Rheumatol. 2003. PMID: 12563702

4

Use of methotrexate in juvenile idiopathic arthritis.

Ramanan AV, Whitworth P, Baildam EM. Ramanan AV, et al. Arch Dis Child. 2003 Mar;88(3):197-200. doi: 10.1136/adc.88.3.197. Arch Dis Child. 2003. PMID: 12598376 Free PMC article. Review.

5

Macrophage activation syndrome--what's in a name!

Ramanan AV, Schneider R. Ramanan AV, et al. J Rheumatol. 2003 Dec;30(12):2513-6. J Rheumatol. 2003. PMID: 14719185 Review. No abstract available.

6

Favorable outcome in patients with renal involvement complicating macrophage activation syndrome in systemic onset juvenile rheumatoid arthritis.

Ramanan AV, Rosenblum ND, Feldman BM, Laxer RM, Schneider R. Ramanan AV, et al. J Rheumatol. 2004 Oct;31(10):2068-70. J Rheumatol. 2004. PMID: 15468377

7

What does "active disease" mean? patient and parent perceptions of disease activity in the systemic arthritis form of juvenile idiopathic arthritis (SO-JIA).

Batthish M, Schneider R, Ramanan AV, Achonu C, Young NL, Feldman BM. Batthish M, et al. Among authors: ramanan av. Rheumatology (Oxford). 2005 Jun;44(6):796-9. doi: 10.1093/rheumatology/keh597. Epub 2005 Mar 22. Rheumatology (Oxford). 2005. PMID: 15784631

8

Does systemic-onset juvenile idiopathic arthritis belong under juvenile idiopathic arthritis?

Ramanan AV, Grom AA. Ramanan AV, et al. Rheumatology (Oxford). 2005 Nov;44(11):1350-3. doi: 10.1093/rheumatology/keh710. Epub 2005 Jun 14. Rheumatology (Oxford). 2005. PMID: 15956091 Review.

9

Developing a disease activity tool for systemic-onset juvenile idiopathic arthritis by international consensus using the Delphi approach.

Ramanan AV, Schneider R, Batthish M, Achonu C, Ota S, McLimont M, Young NL, Feldman BM. Ramanan AV, et al. Rheumatology (Oxford). 2005 Dec;44(12):1574-8. doi: 10.1093/rheumatology/kei095. Epub 2005 Sep 13. Rheumatology (Oxford). 2005. PMID: 16159950

10

Psoriasis after treatment of juvenile idiopathic arthritis with etanercept.

Peek R, Scott-Jupp R, Strike H, Clinch J, Ramanan AV. Peek R, et al. Among authors: ramanan av. Ann Rheum Dis. 2006 Sep;65(9):1259. doi: 10.1136/ard.2005.049916. Ann Rheum Dis. 2006. PMID: 16905590 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

261 results

Search Page